Gianluigi Reda

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 271 citations · Full text

Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes

Valeria Santini, Domenico Girelli, Alessandro Sanna et al. · PLoS ONE · 2011 · 135 citations · Full text

Hepcidin Levels, Immunology, Refractory Anemia +16

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes

Guillermo Garcia‐Manero, Valeria Santini, António Almeida et al. · Journal of Clinical Oncology · 2021 · 75 citations · Full text

<i>BTK</i> and <i>PLCG2</i> remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Silvia Bonfiglio, Lesley‐Ann Sutton, Viktor Ljungström et al. · Blood Advances · 2023 · 62 citations · Full text